Retatrutide
GLP-1 Peptide · 5mg~40mg
MOQ: 10 vials / 1 box
Wholesale Pricing$50 - $192
Purity99.740%
Tested15 APR 2026
Supplier Rating★ 4.9
Verified supplierChina
SSRBIOSSRBIO specializes in high-purity peptide manufacturing, GLP-1 research compounds, and global fulfillment. Leveraging years of international logistics experience and comprehensive export documentation, SSRBIO delivers research products worldwide with a customer-first delivery guarantee, including complimentary reshipment or a full refund for eligible undelivered orders.
Priority Express
Compound profile
Retatrutide overview
Learn about Retatrutide, including its molecular class, mechanism of action, research applications, development status, and current market interest.
Overview
Retatrutide is an investigational synthetic peptide designed as a triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptor pathways. It is one of the most closely watched metabolic research compounds because it combines three incretin and energy-balance signalling pathways in a single molecule.
Molecular Class
Synthetic peptide / incretin-based triple hormone receptor agonist.
Mechanism
Retatrutide is designed to activate glucose-dependent insulinotropic polypeptide receptor, glucagon-like peptide-1 receptor, and glucagon receptor pathways. This combined receptor profile makes it different from single GLP-1 agonists and dual GIP/GLP-1 agonists.
Research Areas
- Obesity research
- Metabolic signalling research
- Type 2 diabetes research
- Liver-fat and MASLD research
- Appetite and satiety pathway research
- Cardiovascular risk-factor research
- Energy expenditure research
- Incretin pharmacology research
Research Status
Retatrutide remains an investigational compound in active clinical development. Lilly is studying it across several Phase 3 programs, including obesity, type 2 diabetes, sleep apnea, osteoarthritis, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatotic liver disease.
Market Demand
Global demand is driven by obesity, metabolic disease, GLP-1, and next-generation incretin research. China-based peptide manufacturers frequently list retatrutide in wholesale vial formats for international research buyers.
Supplier listing intelligence
Retatrutide wholesale supplier listing
Listing overview
Retatrutide wholesale listing from SSRBIO offering configurable 5mg to 40mg research vial options for metabolic and GLP-1 peptide research applications. Includes public Janoshik batch verification references, MOQ export ordering, tracked China dispatch fulfilment, and international supplier shipping support.
Purity99.740%
MOQ10 vials / 1 box
MG Range5mg~40mg
SupplierSSRBIO
Supplier details
SSRBIO
CountryChina
Task Number#123810
Report Key4SCEXQFK1VH9
Tested15 APR 2026
Global fulfilment
Shipping lanes
Tracking information is provided once the order has shipped.
Free Express Shipping AvailableOrders over $100 USD qualify for complimentary express shipping.
✓ Free shipping over $100✓ Tracking included✓ Delivery guarantee
FedEx / DHL Express USA2–5 days$29 • Free over $100
FedEx / DHL Express Canada3–7 days$34 • Free over $100
DHL Express United Kingdom3–6 days$29 • Free over $100
DHL / FedEx Europe Express4–8 days$32 • Free over $100
More from this seller
More products from SSRBIO
Browse additional products from the same supplier catalogue.
Frequently Asked Questions
Retatrutide FAQ
Common questions about Retatrutide, including research information, supplier listings, batch testing, availability, and marketplace details.
What is Retatrutide used for in research?
Retatrutide is studied in metabolic, obesity, type 2 diabetes, liver-fat, appetite, and incretin-signalling research models.
What receptors does Retatrutide target?
Retatrutide targets GLP-1, GIP, and glucagon receptors.
What is the CAS number for Retatrutide?
The commonly listed CAS number for Retatrutide is 2381089-83-2.
What is another name for Retatrutide?
Retatrutide is also known as LY3437943 or LY-3437943.
What does a Retatrutide COA show?
A COA should show product identity, batch number, purity result, test method, test date, and ideally HPLC and mass spectrometry evidence.
What is Retatrutide?
Retatrutide is a glp-1 peptide supplied by SSRBIO, featuring public Janoshik-linked batch testing references, 5mg~40mg vial configurations, and China fulfilment support for research-use laboratory workflows.
What MG configurations are available for Retatrutide?
Retatrutide is available in 5mg~40mg configurations depending on SSRBIO inventory availability and supplier stock levels.
Has Retatrutide undergone batch testing?
Retatrutide includes public laboratory testing references and batch information supplied by SSRBIO.
Who supplies this Retatrutide?
SSRBIO is a China-based peptide supplier offering Retatrutide batches with public laboratory testing references and international fulfilment support.
Is Retatrutide intended for human use?
Retatrutide is supplied strictly for laboratory research use only and is not sold for human consumption, medical use, or self-administration.